0691 (0691) Fair Value & Analysis

Basic Materials · Market cap HK$1.2B

0 0691 0691 · HK

PriceHK$0.2650

Fair ValueHK$0.4000

Upside+50.9%

Quality41/100

Evidence: Medium Range HK$0.2706 – HK$0.5318

Fair value as of: Jul 2, 2026

From 13 valuation models · updated today

Share price −28.4% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2650 – HK$1.02 · fair‑value band HK$0.2706 – HK$0.5318 · the HK$0.2650 price screens below the HK$0.4000 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0691 (0691) currently trades at HK$0.2650, while our model-based Fair Value estimate is HK$0.4000 — implying the stock looks roughly 50.9% undervalued today. We read business quality at 41/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 0691 generated revenue of HK$11.1B at a net margin of -9.9%. Revenue declined 27.5% year over year. It earns a return on equity of -7.0%. Net debt stands at HK$2.2B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$11.1B

Revenue growth (YoY) -27.5%

Net margin -9.9%

Return on equity -7.0%

Free cash flow HK$504M FY2025

Operating margin -29.2%

More key figures

EPS (TTM) HK$-0.0600

EPS growth (YoY) -86.9%

Net debt HK$2.2B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0691 reported revenue of HK$11.6B in FY2025 versus HK$24.7B in FY2021, a compound −17.3%/yr. Reported net income was −HK$983M in FY2025.

Revenue −17.3%/yr

FY21 HK$24.7B

FY22 HK$21.5B

FY23 HK$18.1B

FY24 HK$14.5B

FY25 HK$11.6B

Net income

FY21 HK$2.8B

FY22 HK$755M

FY23 −HK$884M

FY24 −HK$141M

FY25 −HK$983M

Is 0691 fairly valued? → Check now

Similar stocks

6 more Building Materials stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
CRH plc CRH	$106.52	$64.08	-40%
Holcim AG HCMLY	$18.75	$9.07	-52%
Heidelberg Materials AG HEI	€185.15	€157.48	-15%
Vulcan Materials Company VMC	$281.38	$116.17	-59%
Martin Marietta Materials, Inc MLM	$609.88	$218.79	-64%
UltraTech Cement Limited ULTRACEMCO	₹10,912	₹4,589	-58%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0691 (0691) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.4000 versus a price of HK$0.2650 — about +51% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 0691?

Our model-based fair value for 0691 is HK$0.4000 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2650.

What is the quality score of 0691?

0691 has a Quality Score of 41/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0691 (0691)?

0691 reported trailing-twelve-month revenue of about HK$11.1B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 0691?

The net profit margin of 0691 is about -9.9%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.